Skip to main content

cancer Archives

Ukrainian oncologists visit Vanderbilt-Ingram Cancer Center

Nov. 30, 2023—A group of Ukrainian oncologists recently visited Vanderbilt-Ingram Cancer Center where they toured research labs, observed tumor board meetings, met with several Vanderbilt oncologists, and attended the 23rd Annual Retreat for Cancer Biology.

Read more


Vanderbilt-led team receives 2023 Endeavor Award from The Mark Foundation for Cancer Research

Oct. 24, 2023—A multidisciplinary team of investigators has received a 2023 Endeavor Award from The Mark Foundation for Cancer Research to support four closely linked projects exploring the fundamental mechanisms that drive the obesity-cancer connection,

Read more


Discovery lecture features computational cancer biologist Pe’er

Sep. 12, 2023—Dana Pe’er, PhD, a pioneer in using machine learning approaches to explore cell identities and interactions, will deliver the next Discovery Lecture on Thursday, Sept. 21.

Read more


VUMC named a Comprehensive Radiopharmaceutical Therapy Center of Excellence

Aug. 23, 2023—Vanderbilt University Medical Center has been designated a Comprehensive Radiopharmaceutical Therapy Center of Excellence by the Society of Nuclear Medicine and Molecular Imaging. It is the only such center in Tennessee.

Read more


Chronic complications from immunotherapies more prevalent and persistent than previously shown among melanoma survivors

Aug. 8, 2023—A Vanderbilt study has found that chronic immunotherapy-related complications are more prevalent and persistent than previously shown among melanoma survivors.

Read more


Study finds hallmarks of T cell exhaustion within hours of tumor exposure

Aug. 3, 2023—Vanderbilt researchers found that T cells become “exhausted” within hours of encountering a tumor, challenging existing ideas about how T cells become dysfunctional.

Read more


Signaling pathways in liposarcomas

Jul. 25, 2023—A broad bioinformatics approach revealed that Hedgehog signaling is upregulated in dedifferentiated liposarcoma, suggesting this pathway may be an early indicator of poor prognosis and a potential therapeutic target.

Read more


Symposium offers new ways to overcome health disparities

Jun. 14, 2023—Ideas for addressing the disproportionate impact of cancer, diabetes, and gastrointestinal diseases on disadvantaged populations were shared recently during a diversity symposium at Vanderbilt University Medical Center.

Read more


Study discovers that tumor mutation burden predicts survival outcome

Jun. 5, 2023—The expected course of a patient's cancer prognosis has traditionally been judged by its type, stage and microscopic aggressiveness, but patients with the same presentation can still have widely divergent outcomes. Researchers from Vanderbilt-Ingram Cancer Center have discovered that differences in tumor mutation burden are a major reason for this divergence.

Read more


Liquid biopsy test may detect early-stage and low DNA-shedding cancers

May. 31, 2023—Vanderbilt research shows that a liquid biopsy-based multicancer early detection (MCED) test could detect 12 types of cancers, including low DNA-shedding cancers and early-stage cancers.

Read more


Study shows palliative care provided at point of oncology surgery does not improve patient outcomes

May. 11, 2023—New Vanderbilt research provides evidence that the addition of palliative care services earlier in the disease process, specifically to patients having surgery for cancer, does not demonstrate benefits to the patients.

Read more


Better adenoma detection

May. 4, 2023—Fluorescent nanoparticles clearly identified colonic adenomas — precursors to colorectal cancer — in mice, and the formulation should translate to clinical use in humans.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more